These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22201736)

  • 21. Targeting Autophagy-Related Epigenetic Regulators for Cancer Drug Discovery.
    Li Y; Yang G; Yang C; Tang P; Chen J; Zhang J; Liu J; Ouyang L
    J Med Chem; 2021 Aug; 64(16):11798-11815. PubMed ID: 34378389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary polyphenols and chromatin remodeling.
    Russo GL; Vastolo V; Ciccarelli M; Albano L; Macchia PE; Ungaro P
    Crit Rev Food Sci Nutr; 2017 Aug; 57(12):2589-2599. PubMed ID: 26357880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma epigenetics: novel mechanisms, markers, and medicines.
    Lee JJ; Murphy GF; Lian CG
    Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
    Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.
    Yang AY; Kim H; Li W; Kong AN
    Curr Top Med Chem; 2016; 16(7):697-713. PubMed ID: 26306989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and classes of epigenetic drugs for cancer.
    Dhanak D; Jackson P
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translational epigenetics: clinical approaches to epigenome therapeutics for cancer.
    Selcuklu SD; Spillane C
    Epigenetics; 2008; 3(2):107-12. PubMed ID: 18437050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
    Castilho RM; Squarize CH; Almeida LO
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone modification therapy of cancer.
    Biancotto C; Frigè G; Minucci S
    Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
    Komar D; Juszczynski P
    Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic regulation of gene expression as an anticancer drug target.
    Ferguson LR; Tatham AL; Lin Z; Denny WA
    Curr Cancer Drug Targets; 2011 Feb; 11(2):199-212. PubMed ID: 21158714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.
    Link A; Balaguer F; Goel A
    Biochem Pharmacol; 2010 Dec; 80(12):1771-92. PubMed ID: 20599773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting epigenetic DNA and histone modifications to treat kidney disease.
    Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
    Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory.
    Bronner C; Chataigneau T; Schini-Kerth VB; Landry Y
    Curr Med Chem; 2007; 14(25):2629-41. PubMed ID: 17979715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
    Reamon-Buettner SM; Borlak J
    Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.